BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37669906)

  • 21. Comprehensive Analysis of the Transcriptome-wide m6A Methylome in Lung Adenocarcinoma by MeRIP Sequencing.
    Mao W; Yu Q; Wang K; Ma Q; Zheng Y; Zhang G; Luo W; Wang N; Wang Y
    Front Oncol; 2022; 12():791332. PubMed ID: 35903698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of YAP1 by N6-Methyladenosine-Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma.
    Chen Y; Ling Z; Cai X; Xu Y; Lv Z; Man D; Ge J; Yu C; Zhang D; Zhang Y; Xie H; Zhou L; Wu J; Zheng S
    Cancer Res; 2022 Feb; 82(4):599-614. PubMed ID: 34916222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N6-methyladenosine (m6A)-mediated up-regulation of long noncoding RNA LINC01320 promotes the proliferation, migration, and invasion of gastric cancer via miR495-5p/RAB19 axis.
    Hu N; Ji H
    Bioengineered; 2021 Dec; 12(1):4081-4091. PubMed ID: 34288797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. YTHDF2 alleviates cardiac hypertrophy via regulating Myh7 mRNA decoy.
    Xu H; Wang Z; Chen M; Zhao W; Tao T; Ma L; Ni Y; Li W
    Cell Biosci; 2021 Jul; 11(1):132. PubMed ID: 34266473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. METTL14-mediated N
    Liu Z; Sun T; Piao C; Zhang Z; Kong C
    Cell Commun Signal; 2022 Mar; 20(1):36. PubMed ID: 35305660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.
    Sui MH; Zhang WW; Geng DM; Sun DJ
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-145 Modulates
    Yang Z; Li J; Feng G; Gao S; Wang Y; Zhang S; Liu Y; Ye L; Li Y; Zhang X
    J Biol Chem; 2017 Mar; 292(9):3614-3623. PubMed ID: 28104805
    [No Abstract]   [Full Text] [Related]  

  • 28. METTL3 m6A-dependently promotes miR-21-5p maturation to accelerate choriocarcinoma progression via the HIF1AN-induced inactivation of the HIF1A/VEGF pathway.
    Ye K; Li L; Wu B; Wang D
    Genes Genomics; 2022 Nov; 44(11):1311-1322. PubMed ID: 36074324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells.
    Li J; Wu L; Pei M; Zhang Y
    J Ovarian Res; 2020 Sep; 13(1):111. PubMed ID: 32948220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CircDUS2L (circ_0039908) promotes lung adenocarcinoma progression by upregulating PGAM1 by acting as a miR-590-5p molecular sponge.
    Tian Q; Guo Y; Liu J; Pang C; Wang Q; Xie Q; Li J
    J Biochem Mol Toxicol; 2023 Sep; 37(9):e23406. PubMed ID: 37392398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hsa_circ_0070661 inhibits cancer progression through miR-556-5p/TEK axis in lung adenocarcinoma.
    Chen Y; Wu Y
    Cancer Biomark; 2023; 37(1):53-66. PubMed ID: 37005879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. YTHDF2 promotes multiple myeloma cell proliferation via STAT5A/MAP2K2/p-ERK axis.
    Hua Z; Wei R; Guo M; Lin Z; Yu X; Li X; Gu C; Yang Y
    Oncogene; 2022 Mar; 41(10):1482-1491. PubMed ID: 35075244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ALKBH5-mediated m6A modification of circCCDC134 facilitates cervical cancer metastasis by enhancing HIF1A transcription.
    Liang L; Zhu Y; Li J; Zeng J; Wu L
    J Exp Clin Cancer Res; 2022 Aug; 41(1):261. PubMed ID: 36028854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The m6A Reader YTHDF2 Promotes Bladder Cancer Progression by Suppressing RIG-I-Mediated Immune Response.
    Zhang L; Li Y; Zhou L; Zhou H; Ye L; Ou T; Hong H; Zheng S; Zhou Z; Wu K; Yan Z; Thiery JP; Cui J; Wu S
    Cancer Res; 2023 Jun; 83(11):1834-1850. PubMed ID: 36939388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The m6A reader YTHDF2 alleviates the inflammatory response by inhibiting IL-6R/JAK2/STAT1 pathway-mediated high-mobility group box-1 release.
    Zeng Z; Lan Y; Zhang L; Chen Y; Gong Y; Zuo F; Li J; Luo G; Peng Y; Yuan Z
    Burns Trauma; 2023; 11():tkad023. PubMed ID: 38026444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N6-methyladenosine methylation-related genes
    Wang Y; Li T; Liu H; Liang Y; Wang G; Fu G; Takatsuki M; Qu H; Jing F; Li J; Jiang M
    Ann Transl Med; 2022 Dec; 10(24):1398. PubMed ID: 36660669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N
    Liu Z; Wang T; She Y; Wu K; Gu S; Li L; Dong C; Chen C; Zhou Y
    Mol Cancer; 2021 Aug; 20(1):105. PubMed ID: 34416901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome.
    Xiao Q; Wu X; Deng C; Zhao L; Peng L; Zhou J; Zhang W; Zhao Y; Fei Y
    Front Med (Lausanne); 2022; 9():959388. PubMed ID: 36465909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ALKBH5/YTHDF2-mediated m6A modification of circAFF2 enhances radiosensitivity of colorectal cancer by inhibiting Cullin neddylation.
    Shao Y; Liu Z; Song X; Sun R; Zhou Y; Zhang D; Sun H; Huang J; Wu C; Gu W; Zheng X; Jiang J
    Clin Transl Med; 2023 Jul; 13(7):e1318. PubMed ID: 37381158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.